Toda_2003_Bioorg.Med.Chem_11_4389

Reference

Title : A conformational restriction approach to the development of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimer's disease - Toda_2003_Bioorg.Med.Chem_11_4389
Author(s) : Toda N , Tago K , Marumoto S , Takami K , Ori M , Yamada N , Koyama K , Naruto S , Abe K , Yamazaki R , Hara T , Aoyagi A , Abe Y , Kaneko T , Kogen H
Ref : Bioorganic & Medicinal Chemistry , 11 :4389 , 2003
Abstract :

Alzheimer's disease (AD) has been treated with acetylcholinesterase (AChE) inhibitors such as donepezil. However, the clinical usefulness of AChE inhibitors is limited mainly due to their adverse peripheral effects. Depression seen in AD patients has been treated with serotonin transporter (SERT) inhibitors. We considered that combining SERT and AChE inhibition could improve the clinical usefulness of AChE inhibitors. In a previous paper, we found a potential dual inhibitor, 1, of AChE (IC50=101 nM) and SERT (IC50=42 nM), but its AChE inhibition activity was less than donepezil (IC50=10 nM). Here, we report the conformationally restricted (R)-18a considerably enhanced inhibitory activity against AChE (IC50=14 nM) and SERT (IC50=6 nM).

PubMedSearch : Toda_2003_Bioorg.Med.Chem_11_4389
PubMedID: 13129577

Related information

Citations formats

Toda N, Tago K, Marumoto S, Takami K, Ori M, Yamada N, Koyama K, Naruto S, Abe K, Yamazaki R, Hara T, Aoyagi A, Abe Y, Kaneko T, Kogen H (2003)
A conformational restriction approach to the development of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimer's disease
Bioorganic & Medicinal Chemistry 11 :4389

Toda N, Tago K, Marumoto S, Takami K, Ori M, Yamada N, Koyama K, Naruto S, Abe K, Yamazaki R, Hara T, Aoyagi A, Abe Y, Kaneko T, Kogen H (2003)
Bioorganic & Medicinal Chemistry 11 :4389